Sandoz Fights Amgen Enbrel Patent
Amgen Inc. and Hoffman-La Roche Inc. were struck with a California federal lawsuit Tuesday from Sandoz Inc. that says a generic form of arthritis drug Enbrel is not infringing two patents...To view the full article, register now.
Already a subscriber? Click here to view full article